Kidney stress study reveals Finerenone's inner workings
NCT ID NCT06244758
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how the drug finerenone affects kidney blood vessels and stress levels in people with type 2 diabetes. Researchers measured blood flow and oxidative stress in the kidneys of 91 adults. The goal was to understand how finerenone works, not to test a cure or treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE2DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinical Research Center Erlangen, Department of Nephrology and Hypertension, University Hospital Erlangen
Erlangen, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple card game could transform diabetes care
- Diabetes drug dorzagliatin under Long-Term safety watch
- Could a smart monitor help pregnant women with diabetes have healthier babies?
- Smart patch and coach app aim to tame diabetes in pregnancy
- Electric zaps to the gut could help control type 2 diabetes
- Calorie cut may unlock Liver's hidden power in diabetes